Value of Heart Rate Lowering Therapy in Acute Myocarditis
NCT ID: NCT06312891
Last Updated: 2024-03-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
150 participants
OBSERVATIONAL
2024-04-01
2025-06-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Early Use of Ivabradine in Heart Failure
NCT03701880
the Role of Ivabradine in Causing AF in Patients With Chronic Coronary Syndrome
NCT05168189
Role of Ivabradine on Heart Rate and Quality of Life in Patients With Mitral Stenosis in Sinus Rhythm
NCT06371222
Effect of Ivabradine and Beta-blockers Combination Versus Beta-blockers Up-titration on Right Ventricular Pacing
NCT01868880
Effect of Ivabradine in Lowering Heart Rate and Quality of Life in Chronic Heart Failure Patients
NCT03710057
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Conventional anti-inflammatory treatment (control group).
No interventions assigned to this group
Conventional ttt PLUS Carvedilol.
No interventions assigned to this group
Conventional ttt PLUS Ivabradine.
Ivabradine
heart rate lowering therapy
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Ivabradine
heart rate lowering therapy
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Presentation: at least one of the following:
* Myopericarditis/ACS-like
* MINOCA
* Arrhythmias: brady or tachyarrhythmias.
* Unexplained compensated acute cardiomyopathy (excluded ischemic, valvular, hypertensive, metabolic, and toxic causes of cardiomyopathy as indicated clinically).
* TTE: LVEF\>40%
* CMR-confirmed myo(peri)carditis (Lake Louise criteria)
Exclusion Criteria
* Connective tissue diseases (-ve ANA).
* Cancer chemotherapy.
* Toxicity from immunotherapy.
* Vaccine-related myocarditis.
* Presence of coronary artery disease.
* Peripartum (occurring during the last month of pregnancy or within 5 months after delivery)
* ECG: atrial fibrillation/flutter.
* Resuscitated sudden death.
* Early/initial phase of decompensated heart failure.
* Tamponade complicating pericarditis unless successfully managed.
18 Years
90 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Assiut University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Sara Mahmoud Moustafa
Resident at student hospital , assiut university
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Heart Hospital
Asyut, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
VOHRLTIAM
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.